Scandinavian CRO wants to grow further with newly established operations in Norway, Finland and Denmark. The vision is to build a strong Nordic CRO company. In order to realize its vision, the owners have strengthened the board with a new chairman.
Ulf Boberg will be the new chairman of Scandinavian CRO. He has a background in the pharmaceutical and CRO industries and has had leading positions in both smaller Life Science companies and major companies in the pharmaceutical industry, including Astra Zeneca. His latest position was at the Uppsala company Miris.
– We very much look forward to Ulf coming to our team at SCRO. Ulf will support the CEO in business and business development matters and he has a lot of experience in the industry. He will therefore be a sounding board and an important advisor to me, said Ulrika Hammarström Lüllmaa, CEO of SCRO.
She hopes Ulf Boberg can set a course that strengthens the company’s market position and takes additional market share.